Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stopping rules for clinical trials.

L S Freedman, D Lowe, P Macaskill

    Statistics in Medicine
    |April 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel clinical trial stopping rule method, integrating clinically significant differences. The approach is compared to standard group sequential designs using a Pancuronium Bromide hemorrhage prevention study in preterm infants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Where can we improve? An evaluation of discrepancies between radiology resident and consultant reports for noncontrast head computed tomography (NCHCT) scans in the emergency department at a tertiary care centre.

    Clinical radiology·2026
    Same author

    Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
    Same author

    Spot size measurement of a deuterium-tritium dense plasma focus using neutron radiography.

    The Review of scientific instruments·2024
    Same author

    Cutaneous adverse drug reactions to fixed-dose combination treatments for TB.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
    Same author

    British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy.

    Clinical and experimental immunology·2022
    Same author

    Follow-up arrangements in head and neck cancer clinics during the COVID-19 pandemic: results from two tertiary UK head and neck cancer centres.

    Annals of the Royal College of Surgeons of England·2021
    Same journal

    Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

    Statistics in medicine·2026
    Same journal

    Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

    Statistics in medicine·2026
    Same journal

    Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

    Statistics in medicine·2026
    Same journal

    Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

    Statistics in medicine·2026
    Same journal

    Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

    Statistics in medicine·2026
    Same journal

    Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

    Statistics in medicine·2026
    See all related articles

    Area of Science:

    • Clinical Trials Methodology
    • Biostatistics
    • Neonatal Medicine

    Background:

    • Clinical trial design often uses fixed endpoints.
    • Group sequential designs allow early stopping but may not fully capture clinical importance.
    • Establishing meaningful treatment effect thresholds is crucial for ethical and efficient trials.

    Purpose of the Study:

    • To present a new method for formulating stopping rules in clinical trials.
    • To incorporate the concept of a clinically important difference into trial design.
    • To compare this novel method with conventional group sequential designs.

    Main Methods:

    • Development of a new statistical framework for sequential trial analysis.
    • Integration of a pre-defined clinically important difference into the stopping rule calculation.

    Related Experiment Videos

  • Application and comparison of the method using a simulated or real clinical trial dataset.

    • Main Results:

    • The new method provides a flexible approach to defining stopping boundaries.
    • Comparison with conventional methods highlights differences in early stopping recommendations.
    • The application to Pancuronium Bromide demonstrates practical utility in neonatal research.

    Conclusions:

    • The proposed method offers a valuable alternative for clinical trial stopping rules.
    • Incorporating clinically important differences enhances the relevance and efficiency of trial conduct.
    • This approach may lead to more informed decisions regarding trial termination or continuation.